Nepafenac

FDA Approved: * October 16, 2012
Pharm Company: * ALCON RES
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nepafenac Overview

Nepafenac (brand name Nevanac or Ilevro) is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery.[1] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 activity.[2][3] Contents 1 Medical uses 2 Pharmacology 2.1 Mechanism of action 3 Adverse events 4 Regulatory 4.1...

Read more Nepafenac Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nepafenac

Recent Nepafenac Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Nepafenac: (1 result)

Sorted by National Drug Code

• 0065-1750 Ilevro 3 mg/ml Ophthalmic Suspension by Alcon Laboratories, Inc.

Other drugs which contain Nepafenac or a similar ingredient: (1 result)

• NEVANAC Nepafenac14 discussions